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BACKGROUND: Severe sepsis is a common, costly, and
complex problem, the epidemiology of which has only been
well studied in the intensive care unit (ICU). However, nearly
half of all patients with severe sepsis are cared for outside
the ICU.
OBJECTIVE: To determine rates of infection and organ sys-
tem dysfunction in patients with severe sepsis admitted to
non-ICU services.
DESIGN: Retrospective cohort study.
SETTING: A large, tertiary, academic medical center in the
United States.
PATIENTS: Adult patients initially admitted to non-ICU
medical services from 2009 through 2010.
MEASUREMENTS: All International Classification of Dis-
eases, 9th Revision, Clinical Modification diagnosis codes
were screened for severe sepsis. Three hospitalists
reviewed a sample of medical records evaluating the char-
acteristics of severe sepsis.
RESULTS: Of 23,288 hospitalizations, 14% screened posi-
tive for severe sepsis. A sample of 111 cases was manually
reviewed, identifying 64 cases of severe sepsis. The mean
age of patients with severe sepsis was 63 years, and 39%
were immunosuppressed prior to presentation. The most
common site of infection was the urinary tract (41%). The
most common organ system dysfunctions were cardiovas-
cular (hypotension) and renal dysfunction occurring in 66%
and 64% of patients, respectively. An increase in the num-
ber of organ systems affected was associated with an
increase in mortality and eventual ICU utilization. Severe
sepsis was documented by the treating clinicians in 47% of
cases.
CONCLUSIONS: Severe sepsis was commonly found and
poorly documented on the wards at our medical center. The
epidemiology and organ dysfunctions among patients with
severe sepsis appear to be different from previously
described ICU severe sepsis populations. Journal of Hospi-
tal Medicine 2013;8:243–247. VC 2013 Society of Hospital
Medicine
The International Consensus Conference (ICC) for
sepsis defines severe sepsis as an infection leading to
acute organ dysfunction.1,2 Severe sepsis afflicts over
1 million patients each year in Medicare alone, and is
substantially more common among older Americans
than acute myocardial infarction.3–5 Recently, the
Agency for Healthcare Research and Quality identified
severe sepsis as the single most expensive cause of
hospitalization in the United States.6 The incidence of
severe sepsis continues to rise.4,5
Severe sepsis is often mischaracterized as a diagno-
sis cared for primarily in the intensive care unit (ICU).
Yet, studies indicate that only 32% to 50% of
patients with severe sepsis require ICU care, leaving
the majority on the general care wards.7,8 These stud-
ies also reveal mortality rates of 26% to 30% among
patients with severe sepsis who are not admitted to an
ICU compared to 11% to 33% in the ICU.7,8
Although a number of epidemiologic and interven-
tional studies have focused on severe sepsis in the
ICU,3,9,10 much less is known about patients cared for
on the general medicine wards. Without this informa-
tion, clinicians cannot make informed choices about
important management decisions such as targeted
diagnostic testing, empirical antimicrobials, and other
therapies. To this end, we sought to further character-
ize the infectious etiologies and resultant organ system
dysfunctions in the subset of patients with severe
sepsis admitted to non-ICU medical services at a
tertiary academic medical center.
METHODS
Population/Setting
All hospitalizations of adult patients (18 years old)
who were initially admitted to non-ICU medical serv-
ices at the University of Michigan Hospital during
2009 through 2010 were included. The University of
Michigan Hospital has 610 general medical-surgical
beds, including telemetry beds, with closed ICUs
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comprised of 179 beds staffed by intensivists. Patients
transferred from other hospitals and those admitted to
non-medical services were excluded.
Data Abstraction and Definitions
All International Classification of Diseases, 9th Revi-
sion, Clinical Modification (ICD-9-CM) diagnosis
codes for hospitalizations were screened using a previ-
ously published and validated algorithm for severe
sepsis.11 Following this screening, 3 randomly selected
round-numbered batches of hospitalizations were
sampled with subsequent application of the exclusion
criteria. Medical records including physicians’ notes,
consultants’ notes, nurses’ notes, physical therapy
notes, discharge coordinators’ notes, emergency room
flow sheets, as well as ward flow sheets were reviewed
in detail by 3 practicing hospitalists using a structured
instrument closely aligned with the ICC definition of
severe sepsis.2 We also sampled a smaller number of
patients whose ICD-9-CM diagnoses screened negative
for severe sepsis. Sample size was selected as part of a
project with multiple objectives, and reflected a prag-
matic balance between the anticipated precision of the
results and the resources available to conduct chart
review.11 All discrepancies were reconciled among the
3 reviewers.
Reviewers first assessed whether infection was pres-
ent, then evaluated for evidence of each organ system
dysfunction, and finally determined the extent to
which those organ dysfunctions were a response to
the infection. Infection was defined either as a patient
with a microbiologic culture growing a pathologic or-
ganism in a normally sterile site or documentation of
a suspected infection with other confirmatory evidence
(radiological, physical exam finding) with resultant
systemic inflammatory response and administration of
antimicrobials. Community-acquired and healthcare-
associated infections were not differentiated. Micro-
biologic data, confirmatory tests, and site of infection
were abstracted in detail.
Organ dysfunction was defined as per the 2001 ICC
criteria,2 and was assessed for neurological, pulmo-
nary, cardiovascular, renal, gastrointestinal, hemato-
logical, and hepatic system involvement in all
patients. A summary of these clinical definitions is
included in Table 1. Data on important comorbidities
were also abstracted. Immunosuppression was defined
as having any of the following: solid organ transplant,
bone marrow/stem cell transplant, human immunode-
ficiency virus/acquired immunodeficiency syndrome,
neutropenia (absolute neutrophil count <1000), he-
matologic malignancy, solid organ malignancy with
chemotherapy within the past 12 months, or pharma-
cologic immunosuppression (prednisone >20 mg daily
for >4 weeks, calcineurin inhibitor, methotrexate, tu-
mor necrosis factor inhibitors, azathioprine, sulfasala-
zine, hydroxychloroquine). Last, each chart was
evaluated for the presence of explicit documentation
with the presence of the words or phrases: “sepsis,”
“septic shock,” or “severe sepsis,” indicating that the
clinical service recognized and fully documented that
a patient had severe sepsis.
Data Analysis
Methods for assessment of reviewer concordance have
been previously described and were summarized using
the kappa statistic.11 Initial data extraction was per-
formed in SAS 9.1 (SAS Institute, Cary, NC) and all
analyses were conducted in Stata 12 (StataCorp LP,
College Station, TX). Binomial 95% confidence inter-
vals (CIs) are presented. This project was approved by
the University of Michigan Institutional Review
Board.
RESULTS
Of 23,288 hospitalizations examined from 2009
through 2010, the ICD-9–based automated screen for
severe sepsis was positive for 3,146 (14 %). A random
sample of 111 medical records, of which 92 had
screened positive for severe sepsis and 19 had screened
negative, was reviewed in detail. After review by the
hospitalists, 64 of these 111 hospitalizations were
judged to have severe sepsis, 61 of the 92 screened
positive cases (66%), and 3 of the 19 screened nega-
tive cases (16%). The 3 reviewers had a kappa of
0.70, indicating good agreement.
Characteristics of the 64 patients with severe sepsis
are shown in Table 2. The mean age was 63 years old
(standard deviation [SD]517.7), and 41% were male.
The mean length of stay was 13.7 days (SD520.8).
Thirty-nine percent (95% CI, 27%-52%) of patients
(25/64) were immunosuppressed. Of patients initially
admitted to the general medical ward, 25% (16/64;
95% CI, 15%-37%) ultimately required ICU care dur-
ing their admission. The overall in-hospital mortality
rate was 13% (8/64; 95% CI, 6%-23%). Immunosup-
pressed patients had a mortality rate of 20% and non-
immunosuppressed patients had a mortality rate of
8%. Only 47% (30/64; 95% CI, 34%-60%) of the
TABLE 1. Organ System Dysfunction Parameters as
Defined by the 2001 International Consensus
Conference1,2
Organ System Parameters to Indicate Dysfunction
Cardiovascular Systolic BP <90, elevated lactate, MAP <70, requiring pressors >2 hours,
decrease in systolic BP of >40
Renal Creatinine increase >0.5 mg/dL, oliguria
Neurological Acute mental status changes
Pulmonary Intubation, BiPAP, supplemental oxygen >6 LPM or 40% face mask,
PaO2/FiO2 <300
Hematologic INR >1.5 or PTT >60 not on anticoagulation, platelets <100 or 50%
of baseline
Ileus Decreased bowel motility requiring a change in diet
Hepatic Bilirubin >4 mg/dL and >1.5 3 baseline
NOTE: Abbreviations: BiPAP, bilevel positive airway pressure, BP, blood pressure; dL, deciliter; FiO2,
fraction of inspired oxygen; INR, international normalized ratio; LPM, liters per minute; MAP, mean arterial
pressure; mg, milligram; PaO2, partial pressure of oxygen in arterial blood; PTT, partial thromboplastin time.
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medical records had explicit clinician documentation
of severe sepsis.
The most common site of infection was found to be
the genitourinary system, occurring in 41% (26/64;
95% CI, 29%-54%) of patients (Table 3). Pulmonary
and intra-abdominal sites were also common,
accounting for 14% (95% CI, 6.6%-25%) and 13%
(95% CI, 5.6%-23%) of sites, respectively. An infect-
ing organism was identified by culture in 66% (42/64;
95% CI, 53%-77%) of case patients with specific
pathogens listed in Table 4. Among patients with pos-
itive culture results, the majority grew Gram-negative
organisms (57%; 95% CI, 41%-72%). Non-Clostrid-
ium difficile Gram-positive organisms were also prom-
inent and identified in 48% (95% CI, 32%-64%) of
positive cultures. Candida was less common (12%,
95% CI, 4.0%-26%). Fourteen cases (22%, 95% CI,
10%-30%) had 2 or more concomitant infectious
pathogens.
All 64 patients had at least 1 organ dysfunction, as
required by the ICC definition of severe sepsis. Organ
dysfunction in 2 or more organ systems occurred in
77% (95% CI, 64%-86%) of the cases (49/64). The
incidence for each organ system dysfunction is pre-
sented in Table 5, as well as its relationship to both
mortality and ICU admission. The most common
organ system dysfunctions were found to be
cardiovascular (hypotension) and renal dysfunction
occurring in 66% and 64% of the cases, respectively.
In this non-ICU population, pulmonary dysfunction
occurred in 30% of cases, but was frequently associ-
ated with transfer to the ICU, as 63% of the patients
with pulmonary failure required ICU care. Patients
with more organ systems affected were more likely to
be transferred to the ICU and to die.
TABLE 2. Demographics and Characteristics of
Patients With Severe Sepsis (N564)
Age, mean (SD), y 63 (18)
Male sex, no. (%) 26 (41)
Preexisting conditions, no. (%)
History of diabetes 20 (31)
End stage renal disease on chronic dialysis 2 (3)
Chronic obstructive pulmonary disease on oxygen 3 (5)
History of cancer 15 (23)
Liver cirrhosis 5 (8)
Immunosuppression 25 (39)
Median length of stay (days) 7.5
Mean length of stay (SD) 13.7 (20.8)
NOTE: Abbreviations: SD, standard deviation.




Intra-abdominal (not intraluminal) 8 (13)
Bloodstream/cardiac 5 (8)
Skin and soft tissue 4 (6)
GI lumen 4 (6)
Joint 2 (3)
Multiple sites 4 (6)
Unknown 2 (2)







Growing at Least One
of the Pathogens,
N542, No. (%)*
Gram-negative pathogens 30 (47) 24 (57)
Escherichia coli 12 (19) 12 (29)
Escherichia coli (multidrug resistant) 2 (3) 2 (5)
Klebsiella 6 (9) 5 (12)
Pseudomonas aeruginosa 6 (9) 4 (10)
Pseudomonas aeruginosa
(multidrug resistant)
2 (3) 2 (5)
Other† 6 (9) 6 (14)
Gram-positive pathogens 29 (45) 25 (59)
Enterococcus 14 (22) 13 (31)
Vancomycin-resistant Enterococcus
species
5 (8) 4 (10)
Staphylococcus aureus 7 (11) 7 (17)
Methicillin-resistant Staphylococcus
aureus
3 (5) 3 (7)
Streptococcus pneumoniae 2 (3) 2 (5)
Coagulase-negative staphylococci 1 (2) 1 (2)
Clostridium difficile 5 (8) 5 (12)
Fungi
Candida species 5 (8) 5 (12)
Mycobacterium avium 1 (2) 1 (2)
Two organisms 9 (21)
Three or more organisms 5 (12)
*Multiple responses per patient possible. †Other includes Citrobacter, Enterobacter, Proteus, Achromo-
bacter xylosoxidans, and Fusobacterium.
TABLE 5. Incidence and Outcomes of Organ







Number of failed organs, N 5 64
1 15 (23%) 0 (0%) 0 (0%)
2 25 (39%) 2 (8%) 0 (0%)
3 7 (11%) 2 (29%) 1 (14%)
4 10 (16%) 6 (60%) 3 (30%)
>4 7 (11%) 6 (86%) 4 (57%)
Types of organ system dysfunction, all patients, N5 64*
Cardiovascular 42 (66%) 16 (38%)† 8 (19%)‡
Renal 41 (64%) 10 (24%)† 5 (12%)‡
Central nervous system 35 (54%) 14 (40%)† 7 (18%)‡
Pulmonary 19 (30%) 12 (63%)† 8 (42%)‡
Hematologic 15 (23%) 6 (40%)† 6 (40%)‡
GI (ileus) 8 (13%) 5 (63%)† 1 (13%)‡
Hepatic 5 (8%) 4 (80%)† 2 (40%)‡
NOTE: Abbreviations: GI, gastrointestinal; ICU, intensive care unit.
*Multiple responses per patient possible. †Percentage of patients with each organ system dysfunction
who needed ICU care while in the hospital. ‡Percentage of patients with organ system dysfunction who died
while in the hospital.
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DISCUSSION
Severe sepsis was common among patients admitted
to the general medical ward in this tertiary care cen-
ter. Our patient cohort differed in important ways
from previously described typical cases of severe sepsis
among ICU populations. Severe sepsis on the general
medical wards was more commonly associated with
Gram-negative pathogens in the setting of genitouri-
nary tract infections. This is in contrast to Gram-
positive organisms and respiratory tract infections,
which are more common in the ICU.3,10 Renal and
cardiac dysfunction were commonly observed organ
failures, whereas in the ICU, severe sepsis has been
reported to more likely involve respiratory failure.
These results suggest that hospitalists seeking to pro-
vide evidence-based care to prevent postsepsis morbid-
ity and mortality for their non-ICU patients need to
heighten their index of suspicion when caring for an
infected patient and appreciate that many severe sepsis
patients may not fit neatly into traditional sepsis treat-
ment algorithms.
Studies characterizing severe sepsis in the ICU
setting indicate a predominance of pulmonary infec-
tions and respiratory failure with occurrence rates of
74% to 95% and 54% to 61%, respectively.3,12,13
Given that either shock or pulmonary dysfunction is
often required for admission to many ICUs, it is per-
haps not surprising that these rates are dramatically
different on the general medicine ward, with a relative
scarcity of pulmonary infections (14%) and respira-
tory dysfunction (30%). Instead, genitourinary
infections were noted in 41% (95% CI, 29%-54%) of
the cases, in contrast to the rates of genitourinary
infections in ICU patients with severe sepsis, which
have rates of 5.4% to 9.1%.3,10 Likely as a result of
this, a Gram-negative predominance is noted in the
associated microbiology. Furthermore, our study indi-
cates that C difficile and vancomycin-resistant Entero-
coccus (VRE) species appear to represent an emerging
cause of severe sepsis on the general medicine wards,
as they have not been noted to be causative micro-
organisms in previous studies of sepsis. This is
concordant with other studies showing increases in
incidence and severity of disease for C difficile as well
as VRE.14,15
Previous epidemiologic studies of severe sepsis origi-
nating outside the ICU are lacking, but some work
has been done. One study on the epidemiology of
sepsis both with and without organ dysfunction aggre-
gated all hospitalized patients and included those both
admitted to the general medicine wards and directly
to the ICU.7 Similar to our study, this study also
found a predominance of Gram-negative causative
organisms, as well as comparable in-hospital mortality
rates (12.8% vs 13%). Additionally, genitourinary
infections were noted in 20% of the patients, notably
higher than rates reported to have been found in
patients with severe sepsis in the ICU, but not the
magnitude found in our study, perhaps as a result of
the combined ICU-ward population studied. A similar
high prevalence of genitourinary infections was also
noted in a recent administrative data-based study of
emergency medical services-transported patients with
severe sepsis, half of whom required intensive care
during their hospitalization.16
Our study is unique in that it focuses on severe sep-
sis in patients, commonly cared for by hospitalists,
who were admitted to the general medical ward, and
uses patient level data to elucidate more characteris-
tics of the defining organ dysfunction. Furthermore,
our results suggest that severe sepsis was poorly docu-
mented in this setting, indicating a potential impact
on billing, coding, case mix index, and hospital
mortality statistics that rely on very specific wording,
as well as a possible need for increased awareness
among hospitalists. Without this awareness, an oppor-
tunity may be missed for improved patient care via
specific sepsis-targeted measures,13,17,18 including
more aggressive resuscitative measures19 or intensive
physical and occupational therapy interventions aimed
at impacting the cognitive and functional debilities20
that result from severe sepsis. Highlighting this grow-
ing need to better assist clinicians assess the severity
of septic patients and recognize these complex cases
on the general medicine wards, 1 recent study eval-
uated the fitness of several clinical disease-severity
scoring systems for patients with sepsis in general
internal medicine departments.21 Perhaps with the
help of tools such as these, which are being piloted in
some hospitals, the care of this growing population
can be enhanced.
Our study has a number of limitations that should
be kept in mind. First, this is a single center study
performed at an academic tertiary care center with a
relatively high incidence of immunosuppression, which
may influence the spectrum of infecting organisms.
Our center also has a relatively large, closed-model
ICU, which often operates at near capacity, poten-
tially affecting the severity of our non-ICU popula-
tion. Second, although we screened a large number of
patients, as necessitated by our intensive and detailed
review of clinical information, our sample size with
hospitalist-validated severe sepsis is relatively small.
With this small sample size, less prevalent infections,
patient characteristics, and organ dysfunctions may by
chance have been under or over-represented, and one
could expect some variance in the occurrence rates of
organ system dysfunction and infection rates by
sampling error alone. Further larger scale studies are
warranted to confirm these data and their generaliz-
ability. Third, the data necessary to calculate sequen-
tial organ failure assessment or multiple organ
dysfunction score were not collected. This may limit
the ability to directly compare the organ dysfunction
noted in this study with others. Additionally, given
the ICC definitions of organ dysfunction, some of the
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organ dysfunction noted, particularly for neurological
dysfunction, was reliant on subjective clinical findings
documented in the record. Finally, we relied on the
lack of specific terminology to indicate a lack of
documentation of sepsis, which does not necessarily
indicate a lack of recognition or undertreatment of
this condition. However, these limitations are offset
by the strengths of this study, including the patient-
level medical record validation of severe sepsis by
trained hospitalist physicians, high kappa statistic,
and strict application of guideline-based definitions.
This work has important implications for both
clinicians and for future research on severe sepsis. The
results suggest that severe sepsis may be quite com-
mon outside the ICU, and that patients presenting
with this condition who are admitted to general
medical wards are not routinely characterized by the
profound hypoxemia and refractory shock of iconic
cases. Certainly, further study looking at larger
numbers of cases is needed to better understand the
specifics and nuances of this important topic as well
as to further evaluate clinicians’ ability to recognize
and treat such patients in this setting. Furthermore,
future research on the treatment of severe sepsis,
including both antimicrobials and disease-modifying
agents (eg, anti-inflammatories) must continue to
include and even focus on this large population of
non-ICU patients with severe sepsis, as the risk/benefit
ratios of such potential treatments may vary with
severity of illness.
In conclusion, severe sepsis was commonly found in
patients admitted on the general medicine wards. The
epidemiology of the infections and resultant organ
dysfunction appears to differ from that found in the
ICU. More studies are needed to provide a deeper
understanding of this disease process, as this will
enable clinicians to better recognize and treat patients
thus afflicted, no matter the setting.
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